| Detected | Trial | Change |
|---|---|---|
| 2026-05-23 | NCT05063162 A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With… |
Trial sites reduced: 73 -> 55 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07246564 | Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese… | Myasthenia Gravis | Recruiting |
| Phase 3 | |||
| NCT07465289 | A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult… | Ocular Myasthenia Gravis | Not Yet Recruiting |
| NCT07463521 | A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With… | Ocular Myasthenia Gravis | Not Yet Recruiting |
| NCT06540144 | An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric… | Generalized Myasthenia Gravis | Enrolling by Invitation |
| NCT05063162 | A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With… | Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD) | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT06149559 | A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe… | Generalized Myasthenia Gravis | Recruiting |